Pipeline

Home
  • Biologics
  • Chemical
  • Medical Device
  • DTx

Scroll left to right.

Comparison table of pipeline areas, projects, classification, indication, Research, pre-clinical, phase 1 clinical trials, phase 2 clinical trials, and phase 3 clinical trials
Therapeutic Area Project Category Indication Research Pre-clinical Phase I Phase II Phase III Remarks
Orphan

HL2356

(GX-H9)

 Bio-better Growth Hormone Deficiency in Adults
  • Genexine: Licensor
  • Handok: Korea right for development and commercialization
Growth Hormone Deficiency in Pediatrics

China
Orphan/ Metabolism

RZ358

 Bio Intravenous monoclonal antibody
for Congenital Hyperinsulinism

Europe
  • Rezolute: Licensor
  • Handok: Korea right for development and commercialization

RZ402

 Small Molecules Oral Plasma Kallikrein Inhibitor
for Diabetic Macular Edema
Oncology HD-B001A VEGF/DLL4 Cancer
  • ABL Bio: Licensor
  • Handok: Korea right, collaboration with Compass Therapeutics for global clinical trial phase 2,3
HL5101 NCE Solid cancer
  • Handok/CMG Pharma: Licensor
  • AUM Bioscience: Global right for development and commercialization excluding Korea
SBP-101 Small Molecules Melanoma, BTC, GBM
  • SPARK Biopharma: Licensor
  • Handok: Korea right for development and commercialization
ABL103 Immuno-Oncology Solid cancer
  • ABL Bio: Licensor
  • Handok: Korea right for development and commercialization
ABL501
ABL503
Derma SCM-AD Stem Cell Therapy Atopic Dermatitis
  • SCM Lifescience: Licensor
  • Handok: Korea right for development and commercialization
Comparison table of pipeline areas, projects, category, indication, product development, clinical trials, and regulatory approval
Medical Device Project Category Indication Development Clinical Regulatory Approval Remarks
CV/
Infection		 RST Kit Diagnostics CV/
Infection 		Handok: Global commercialization right
Comparison table of pipeline areas, projects, category, indications, Discovery, POC, Pivotal, Regulatory, and Commercial
Digital Health Project Category Indication Discovery POC Pivotal Regulatory Commercial Remarks
CNS WELT-I DTx Insomnia
  • Welt: Licensor
  • Handok: Korea right for development and commercialization
WELT-A Alcoholism
TOP